AVMA revises biotechnology policy
Schaumburg, Ill. -- The American Veterinary Medical Association?s (AVMA) Executive Board revised its policy on ?Use of Biotechnology in Development of Drugs and Vaccines? in April.
Schaumburg, Ill.
-- The American Veterinary Medical Association’s (AVMA) Executive Board revised its policy on “Use of Biotechnology in Development of Drugs and Vaccines” in April.
The revisions officially recognize the importance of biotechnology in drug and vaccine development, revealing how biotechnology use can help enhance surveillance and evaluate new developments with a science-based approach.
The amended policy can be found here.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
